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Given many reports of contaminant-associ-
ated reproductive and developmental
impacts in wildlife, often considered to be
caused by endocrine disruption, there is now
a major global effort to develop ecotoxicity
test guidelines for the hazard assessment of
endocrine disruptors. The Endocrine
Disruptor Screening and Testing Advisory
Committee (EDSTAC) (1) and the U.S.
Environmental Protection Agency’s (U.S.
EPA’s) proposed Endocrine Disruptor
Screening Program (EDSP) (2) have made
key initiatives for hazard assessment per se.
Critically, however, the strategy for ecologi-
cal effects characterization of endocrine dis-
ruptors also needs to be integrated into the
exposure characterization component of a
risk-based laboratory and field approach
(3,4).
The European Centre for Ecotoxicology
and Toxicology of Chemicals (ECETOC)
established the Environmental Oestrogens
Task Force to identify the best ways to eval-
uate potential endocrine-disrupting sub-
stances for human and ecological risk
assessment. From these efforts, our ECE-
TOC working group argues for an ecologi-
cal risk assessment framework for endocrine
disruptors and supports the establishment of
new wildlife screening and testing protocols.
Our strategy for ecotoxicity screening and
testing is discussed versus the proposed EDSP
(2), based on the earlier report from the
EDSTAC (1). Specifically, our critical review
of the EDSTAC considers both the scientific
rationale and ethical use of animals for eco-
toxicity hazard assessment (5). Throughout
this exercise, we support the internationally
agreed definition from the 1996 Weybridge
workshop, whereby an endocrine disruptor is
“an exogenous substance which causes adverse
effects in an organism, or its progeny, subse-
quent to changes in the endocrine system.”
(6). In vitro test systems are not addressed in
our present discussion because it has been
widely agreed at several international work-
shops that endocrine-disruptor assessments in
wildlife should primarily focus on in vivo
studies (7,8).
The Ecological Risk
Assessment Context
Although evaluation of endocrine disruptors
is a relatively new area, both field and labora-
tory studies have been conducted to define
ecological effects, determine sources, and
characterize the ecological risk of selected
endocrine-active substances. For example,
recent progress toward this goal is illustrated
by tributyltin (9). In general, however, further
work is needed to evaluate potential
endocrine disruptors within the established
ecological risk assessment concept (2,10,11)
(Figure 1). Although much will be learned
through the on-going application of the eco-
logical risk assessment paradigm to both nat-
ural and synthetic endocrine disruptors, we
support the views of Kendall et al. (4) in that
“There is no need to develop a new frame-
work for ecological risk assessment of
endocrine disrupters.” What is needed, how-
ever, is a scientifically and ethically justifiable
approach to prioritizing endocrine-disruptor
screening and testing that effectively protects
the diversity of wildlife.
The established risk assessment frame-
work provides a robust tool with which to
evaluate the impacts of natural and synthetic
toxicants, endocrine disruptors, and other
stressors on ecosystems. This framework bal-
ances exposure characterization versus effects
characterization, taking into account the
need for test validation, data acquisition, and
field monitoring. 
Exposure assessment for potential
endocrine disruptors is important in directing
specific-effects testing, such that risk assess-
ment and risk management can proceed.
Exposure assessment may be defined as the
contact between the bioavailable fraction of
the compound of interest and the organisms
of concern. A tiered approach to exposure
assessment whereby conservative assumptions
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The European Centre for Ecotoxicology and Toxicology of Chemicals proposes a tiered approach
for the ecological risk assessment of endocrine disruptors, integrating exposure and hazard
(effects) characterization. Exposure assessment for endocrine disruptors should direct specific tests
for wildlife species, placing hazard data into a risk assessment context. Supplementing the suite of
mammalian screens now under Organization for Economic Cooperation and Development
(OECD) validation, high priority should be given to developing a fish screening assay for detect-
ing endocrine activity in oviparous species. Taking into account both exposure characterization
and alerts from endocrine screening, higher tier tests are also a priority for defining adverse
effects. We propose that in vivo mammalian and fish assays provide a comprehensive screening
battery for diverse hormonal functions (including androgen, estrogen, and thyroid hormone),
whereas Amphibia should be considered at higher tiers if there are exposure concerns. Higher tier
endocrine-disruptor testing should include fish development and fish reproduction tests, whereas
a full life-cycle test could be subsequently used to refine aquatic risk assessments when necessary.
For avian risk assessment, the new OECD Japanese quail reproduction test guideline provides a
valuable basis for developing a test to detecting endocrine-mediated reproductive effects; this
species could be used, where necessary, for an avian life-cycle test. For aquatic and terrestrial
invertebrates, data from existing developmental and reproductive tests remain of high value for
ecological risk assessment. High priority should be given to research into comparative endocrine
physiology of invertebrates to support data extrapolation to this diverse fauna. Key words: ecologi-
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in the estimate are progressively refined is
likewise appropriate for endocrine disruptors
as well as compounds that may be active via
other mechanisms.
Potential for exposure should drive the
selection of appropriate test organisms in
hazard assessment. For example, where a
pesticide is sprayed directly onto crops, it is
reasonable to expect potential exposure to
aquatic organisms and birds via spray drift.
The expected environmental concentrations
should then be compared with the toxic
concentration to aquatic organisms and
birds to determine the potential ecological
risk. For natural or synthetic substances dis-
charged via wastewater into rivers, aquatic
organisms are expected to be exposed if the
substance is not degraded during wastewater
treatment. In addition, the bioaccumulation
and biomagnification potential of the sub-
stance should be assessed to determine if
fish-eating birds and mammals might also
be at risk.
Once potential for exposure is deter-
mined, suitable effects tests should then be
selected and the hazard assessed. The types of
tests used should address the sensitivity of the
faunal populations in the context of diverse
exposure scenarios (Figure 2), adapted from
Solomon (12).
In comparing the degree of toxicity with
the level of exposure, the risk of the com-
pound may then be characterized and any
necessary risk management can be conducted
(Figure 1). Ultimately, potential impacts
from synthetic substances should be consid-
ered in the context of natural stressors to
help define what is an acceptable ecological
impact. The concept of acceptability under-
pins the regulatory programs for pesticides
in many countries. For example, the U.S.
EPA characterizes “unacceptable” as “wide-
spread and repeated mortality in the face of
minor economic benefits to society”
(11,13). Finally, it is essential that new test
methods should provide data that can be
related directly to the field monitoring
method. The successful field and laboratory
measurement of vitellogenin (VTG) induc-
tion in fish illustrates the biological linkage
concept (14).
Overview of Conceptual
Testing Framework
Although we fully support the principle of
EDSTAC’s tiered screening and testing pro-
gram, we suggest that this can be enhanced, as
shown in Figure 3, to provide more ecologi-
cally relevant and responsible use of limited
animals for testing. 
Key elements of our approach are, first,
to focus testing needs through a greater con-
sideration of exposure characterization data
when deciding which types of chronic tests
(e.g., avian, fish, or invertebrate) may be
required at the higher tiers (15). Second, our
scheme offers a pragmatic alternative to the
technical and ethical concerns raised by the
EDSTAC recommendation to move to
extensive multispecies testing directly after
the Tier 1 screening, without first recogniz-
ing the value of partial life-cycle (PLC) tests,
which use fewer animals. The following con-
cepts have proved useful in consideration 
of new wildlife protocols for endocrine-disrup-
tor screening and testing: a) conceptual 
protocol, which refers to an idea for a novel
protocol that has not yet been actually con-
ducted and reported in the peer-reviewed sci-
entific literature; b) developmental protocol, a
protocol that has been published in the peer-
reviewed scientific literature and forms the
basis for further research (e.g., using a range of
reference endocrine-disruptor substances)
toward the development and prevalidation of a
reliable method; and c) validated protocol, the
appropriate term for a protocol that has been
demonstrated to be reliable and reproducible as
a result of appropriate intralaboratory and
interlaboratory comparisons. Protocols need to
achieve the validated status before they can be
reliably employed for regulatory purposes, for
example, within the Organization for
Economic Cooperation and Development
(OECD) test guideline program. 
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Figure 1. The U.S. EPA framework for ecological risk assessment (10).
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Figure 2. Exposure versus population sensitivity
scenarios for persistent or nonpersistent
endocrine disruptors, adapted from Solomon (12).
(A) Exposure and sensitivity periods overlap with
high probability of population effect. (B) The expo-
sure period does not overlap the sensitivity period,
so there is a low probability of population effect.
(C) The exposure period overlaps the early devel-
opmental period of population sensitivity, so there
is an intermediate probability of population effect.
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Screening for Interactions
with Endocrine Systems
In accordance with EDSTAC, we agree on
the need for in vivo screening to identify the
ability of a compound to interact with the
endocrine system, primarily for androgen,
estrogen, or thyroid hormone activities.
Importantly, the purpose of Tier 1 screening
(Figure 3) should be to provide alerts to
endocrine-active substances, whereas higher-
tier tests should provide adverse effects data
for risk assessment application. Previous inter-
national workshops have agreed that screen-
ing with laboratory mammals is sufficiently
comprehensive to cover wild mammalian
species; however, because of their distinct
reproductive physiology, the screening battery
should include oviparous species (7,8). It is
also essential to undertake an efficient num-
ber and range of Tier 1 screens in order to
develop a mechanistic rationale that will allow
differentiation between substances which
directly impact the endocrine system (primary
endocrine effects) versus those substances
which primarily affect other target organs
before causing secondary endocrine effects
(16). As argued by Purchase (17), there is a
need for specific screening assays that use a
minimum number of test animals, taking into
account the environment compartment of
concern for the risk assessment. The candi-
date screening assays included in the
EDSTAC proposals are discussed in the sub-
sequent section.
Frog metamorphosis screening assay.
EDSTAC’s main objective of the inclusion
of the frog (Xenopus laevis) metamorphosis
assay as a Tier 1 screen is to detect thyroid
agonists and antagonists, rather than to rep-
resent amphibians as a taxonomic group (1).
EDSTAC outlines a protocol for Amphibia
in which the larvae (tadpoles) of Xenopus lae-
vis are exposed to the test substance for 14
days, with the tail resorption rate as the main
end point (18). Data are urgently required
for a range of thyroid active and negative
control substances to evaluate the specificity
and sensitivity of the frog metamorphosis
assay before international validation. Failure
to address these needs, especially assay speci-
ficity, will have serious implications for the
numbers of animals tested to detect thyroid
disruption (17,19).
More broadly, thyroid hormones are crit-
ical to the normal processes of development
and reproduction in many animals. The
amphibian assay described by EDSTAC does
not define the necessary experimental design
to specifically detect thyroid disruption. We
therefore recommend that thyroid hormone
disruption may be detected in Tier 1 mam-
malian screens. If (anti-)thyroidal activity was
detected in mammals and if exposure charac-
terization suggested significant exposure in
amphibian habitats, then a suitably validated
frog larval metamorphosis test could be use-
fully deployed at a higher tier (Figure 3).
In many vertebrates, a number of physio-
logic and morphologic processes are influ-
enced by the thyroid (20). Mechanisms of 
thyroid action may vary between species and
among tissues, with alpha- and beta-variant
nuclear receptors having being identified in
mammals (21), whereas frog thyroid hormone
receptors (THRs) are highly homologous to
THRs of other vertebrates. In Amphibia dur-
ing normal development, thyroid hormone
levels rise, resulting in growth and differenti-
ation of the limbs, with tail resorption being
the final gross morphologic change within
metamorphosis. Metamorphosis is initiated
by the binding of thyroid hormone to
α-THR, whereas β-THR is presumed to play
a later role in developmental programs such
as tail resorption. Notably, steroids such as
corticoids can modulate thyroid hormone
activity during amphibian metamorphosis
(enhancement of tail resorption) (22–24).
Also, studies in populations of Great Lakes
salmon have also demonstrated that fish can
be affected by thyroid-disrupting chemicals
(25,26). These observations in wild fish 
suggest that there is an important opportuni-
ty to also detect thyroid disruption in fish
partial and full life-cycle tests. In conclusion,
potential effects on the thyroid hormone sys-
tem should in principle be detected by
rodent mammalian Tier 1 screening. The
decision to evaluate chemical effects in the
frog metamorphosis assay would likely be
best based on a positive result from the mam-
malian thyroid screen, and only if exposure
characterization predicts significant potential
exposure of amphibian habitats. The devel-
opment of a peer-reviewed database on the
sensitivity of fish and amphibians to thyroid
disruptors is an important research priority.
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Figure 3. ECETOC strategy for the hazard and ecological risk assessment of endocrine disruptors. In all
cases, protocols used for both screening and higher tier testing should have gone through international
validation before use.
aOnly required if mammalian screens show evidence of thyroid disruption. bAddressed at the SETAC-OECD invertebrate
workshop (66). cOnly required if the substance is active in the larval amphibian metamorphosis test at Tier 2. dOnly
required if positive in avian reproduction test at Tier 2. eOnly required if the substance is active in fish PLC tests at Tier 2. 
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Fish Screening Assays 
Fish gonadal recrudescence assay. EDSTAC
originally recommended the concept of the
fish gonadal recrudescence assay (GRA),
whereby breeding fathead minnows
(Pimephales promelas) of both sexes would first
be transferred to “winter phase” (short day
length and low temperature) conditions to
inhibit spawning. Once fish were synchro-
nized in this nonbreeding phase, fish would
be transferred to a “summer phase” (increas-
ing day length and temperature regime) to
stimulate gonadal maturation and develop-
ment of secondary sexual characteristics.
Proposed end points include assessment of
gamete quality, fecundity, gross pathology of
gonads, measurement of relative gonad
weight (gonadal somatic index), and measure-
ment of vitellogenin levels (a widely used bio-
marker of estrogen exposure in fish) (8,27).
The disadvantages of the fish GRA
include the absence of any published data on
gonadal recrudescence in OECD test species;
unlike other approaches that seek to enhance
existing regulatory test guidelines for testing
endocrine disruptors (28), the GRA has no
clear link to an existing regulatory protocol,
and the practical use of end points such as
gamete quality and fecundity in such a screen-
ing assay incurs a high degree of interindivid-
ual variability because cyprinid fish have
widely variable fecundity between breeding
pairs, even within control populations. Also,
considering extending the international use of
this approach beyond the fathead minnow,
other OECD fish species (e.g., medaka and
zebrafish) have different breeding require-
ments. For example, some zebrafish popula-
tions have been reported to display a normal
juvenile hermaphrodite stage (29), making
baselines potentially uncertain. Although the
sexes in fathead minnows are usually very dis-
tinct, in other fish species secondary sexual
characteristics in males develop differently as
dominant (territorial) males appear during
group culturing, whereas others show less
obvious secondary sexual characteristics (30).
In zebrafish, for example, the sex of the fish is
difficult to determine when the fish is not in a
reproductive stage. On the other hand,
zebrafish can produce eggs even at suboptimal
conditions; therefore, it is difficult to main-
tain this species in a nonreproductive stage
(31). Overall, there is little prospect that a
small fish GRA could be robust or practical,
or could specifically detect endocrine-active
substances.
Juvenile fish screening assay. An alterna-
tive approach using the juvenile stage of
OECD fish species was originally proposed at
the second Duke workshop, Screening
Methods for Detecting Potential (Anti-)
Estrogenic/Androgenic Chemicals in Wildlife
(8). The use of juvenile fish as the basis of a
screening assay has many advantages and
should be seriously considered as a practical
alternative to the conceptual fathead minnow
GRA. Also, using juvenile fish avoids the
potential problem associated with adult fish
reproductive and territorial behavior, for
example, where the presence of sexually dom-
inant males (or females) may lead to behav-
ioral and pheromone modulation of other
fish in the laboratory population (30). Once
endocrine baselines have been established for
a given fish model, it is possible to use sensi-
tive and specific end points (e.g., VTG
induction) to screen for endocrine activity. 
Using this approach, a number of
research groups have shown that juvenile fish
are very sensitive to estrogens and antiestro-
gens (32–34). Current research sponsored by
the European chemical industry is now
extending the evaluation of this juvenile fish
assay for (anti) androgens and aromatase
inhibitors (35). Adapted from the OECD
test guideline 204 (36), the juvenile fish assay
has significant potential for practical use, a
potential that is currently being critically
evaluated as part of the OECD prevalidation
exercise. 
Higher Tier Tests for Hazard
Assessment
Higher tier tests should serve to identify
effects of concern (e.g., development and
reproduction) that are a consequence of
endocrine disruption, supporting the effects
characterization within ecological risk assess-
ment. Working within the ecological effects
and exposure characterization phases of the
ecological risk assessment guideline (11), if
significant exposure is predicted for a sub-
stance that is active in the Tier 1 mammalian
or fish screens, then higher tier testing for
potential adverse effects (endocrine disrup-
tion) is warranted. At this stage, the key
terms “adverse effects” and “organisms and
their progeny” become critical. Although this
is not apparent within EDSTAC (1), such
testing should be targeted at the specific
ecosystem and wildlife populations of concern
(e.g., aquatic animals or seed-eating birds)
using data on exposure characterization, rather
than unnecessary higher tier testing on all
wildlife groups due to endocrine-disruptor
concerns per se. In contrast, if the mammalian
and fish Tier 1 screens are all negative, then no
further testing for potential endocrine disrup-
tion is justified and the risk characterization
phase should proceed, taking into account all
information (both endocrine and nonen-
docrine related). The candidate higher-tier
testing assays included in the EDSTAC pro-
posals are discussed in the subsequent section.
Avian reproduction testing. Since the
concerns raised over pesticide poisoning of
birds during the 1950s and 1960s, there has
been extensive use of avian reproductive tox-
icity testing in several countries and regions
(37–39). More recently, the OECD is taking
a leading role in promoting international
harmonization of avian testing, including
reproductive toxicity test guidelines and the
new question of the endocrine-disruption in
birds (40). This is warranted given the dis-
tinct reproductive endocrinology of birds,
whereby reproductive dysfunction may be
expressed in terms of impaired egg laying or
abnormal hormonal imprinting of males and
females. Importantly, the “default sex” for
many bird species is the male, whereas in
mammals the “default sex” is female (14).
Avian sex ratios may be more plastic, howev-
er, than was traditionally thought, implying
that sex determination is affected by envi-
ronmental factors (41,42). 
The EDSTAC proposal appears to sug-
gest that for chemicals which are positive in
the Tier 1 screens, avian reproduction testing
is necessary at Tier 2, although the triggers for
requiring such an avian study are not defined.
Specifically, EDSTAC recommends conduct-
ing reproduction tests with two avian species,
northern bobwhite quail (Colinus virginianus)
and mallard duck (Anas platyrhynchos), using
existing protocols with possible modifications
to enhance the ability to detect endocrine-
related effects. The existing avian reproduc-
tion protocols are well known, and it is
estimated that they have been used approxi-
mately 300–500 times (43,44). These meth-
ods are standardized and regarded as
adequately reproducible; hence, protocols for
both northern bobwhite quail and mallard
duck have de facto acceptance by the scientif-
ic community as being valid. The EDSTAC
recommendations for suggested modifications
to the current one-generation avian reproduc-
tion protocol include extending the current
study design to two generations, measuring
circulating sex steroid and thyroid hormones,
and monitoring a suite of morphologic and
functional parameters in offspring.
Higher tier testing with Japanese quail.
The use of Japanese quail (Coturnix coturnix
japonica) promises to be a cost-effective alter-
native for endocrine-disruptor testing, and
the draft revised OECD test guideline 206 is
currently being adapted for this species (45).
In general, reproductive parameters such as
egg production and egg quality, fertility,
embryo survival, hatching success, and
growth and development are part of the cur-
rent draft. Gonad histology is at present not
included as a requirement for the draft-
revised OECD test guideline 206, but histol-
ogy is mentioned in the EDSTAC proposals
as a possible further end point, subject to
research. Also, gonadal gross morphology
and accessory organ development of offspring
may be a valuable addition to the current
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draft in order to evaluate the potential effects
on the endocrine system of birds (7). 
Two-generation avian testing. There are
a number of scientific and practical challenges
in moving directly to an avian two-generation
study following Tier 1 screening with other
species. These include the extension of the
northern bobwhite quail or mallard duck
test protocol to a two-generation study,
makes these tests even longer and more cost-
ly, thus increasing international interest in
the Japanese quail (45) and the modification
mentioned in the EDSTAC report (1) for
extending the current U.S. EPA protocol to
include end points such as plasma steroid
levels, organ weights, and histopathology.
An extensive validation program with
known endocrine disruptors is needed to
identify the potential relevancy of recom-
mended biochemical and neurobehavioral
parameters for developmental and reproduc-
tive effects testing in birds. Extensive control
data in the various avian species of potential
interest are also essential to allow reliable
interpretation of the many parameters in the
EDSTAC proposals, and the specificity of
the various endocrine, behavioral, and mor-
phologic parameters are unknown among
bird species or across chemical groups.
Natural variations in blood hormone
concentrations in most avian species is
unknown; thus, comparisons of experimen-
tally derived laboratory data to baseline nor-
mal values would not be possible without
further research. Because biological signifi-
cance of experimentally derived effects in
birds may be difficult to define, a large
research effort is needed to provide a scien-
tific context in which to interpret the regula-
tory meaning of new end points proposed
for the avian testing tier. The key reason for
using the mallard duck is the demonstrated
ability to show egg-shell thinning after expo-
sure to contaminants (46); however, this
effect has only been observed with a very
small percentage of test compounds. Other
end points (e.g., behavioral tests or steroid
levels) may be added at a later stage, but not
before fundamental research and validation
efforts. Therefore, we propose that for both
scientific and practical purposes, there is a
useful role in higher Tier 2 for the Japanese
quail reproduction test, with the multigener-
ational avian study being more appropriate
for higher Tier 3 (Figure 3).
Fish higher-tier testing. The EDSTAC
proposals include the use of a full life-cycle
test on the freshwater fathead minnow as a
definitive Tier 2 test for endocrine disrup-
tion in fish. Additionally, it is suggested that
other species such as the sheepshead minnow
should be used when estuarine or marine
environments are expected to be exposed to
the test compound. In the fish full life-cycle
(FFLC) test as standardized by the U.S. EPA,
fathead minnows are exposed to the test
compound from the egg (F0 generation) to
early development of the F1 generation off-
spring, with a test duration of approximately
9–10 months. At maturation of the F1 gen-
eration, breeding pairs or groups are formed
to promote spawning (47). The end points
analyzed in the existing FFLC study include
spawning frequency, number of eggs pro-
duced, viability of embryos, hatching success,
growth, and development. The EDSTAC
recommends the addition of other parame-
ters such as gonad weight and histopatholo-
gy, sperm motility and egg maturation, and
plasma VTG and steroid hormone levels.
Although multigenerational studies are
the ultimate test for evaluating the effects of
compounds that may be bioaccumulative or
have specific modes of action posing hazards
to progeny, there are also significant limita-
tions to the current regulatory FFLC
method. A major disadvantage of FFLC tests
is their technical complexity. In fact, because
of these problems and high cost, FFLC tests
are not routinely conducted for any class of
substance. FFLC tests have, for example,
been used to address concerns over persistent
pesticides (48,49) or endocrine-active phar-
maceuticals that affect the reproductive
health of fish (50). EDSTAC proposes that
the FFLC test should be conducted after a
trigger from either the sorting of initial data
or from the screening tier (1). A direct tran-
sition to such a high level definitive test
apparently ignores the practical necessity to
conduct a chronic range-finding test with
the same fish species before conducting an
FFLC test. We therefore recommend incor-
poration of an intermediate testing tier
(Figure 3), including a fish development
(extended embryo-larval) test (51) and a fish
reproduction test based on pair-breeding
adults (52). Our recommendation reflects
the fact that for most chemicals, fish
embryo-larval tests are predictive of effects in
FFLC tests (48,49); a fish development test
will cover the most sensitive stage of sex
determination, whereas an adult fish repro-
duction test will address both specific and
nonspecific impacts on fecundity and related
parameters. The number of substances tested
could be greatly increased, taking into
account the duration and technical chal-
lenges of the studies and the capacities of
laboratories with experience in FFLC tests.
We estimate that probably 10 times more
compounds can be tested worldwide using
these PLC tests versus the EDSTAC propos-
al for FFLC tests (approximately 200 com-
pounds per year as opposed to 20 per year,
respectively).
The addition of new endocrine disrup-
tor-relevant end points requires considerable
development and validation before they can
be considered useful for regulatory purposes.
Subsequently, end points may best be target-
ed at the endocrine mechanisms of interest
on a case-by-case basis, depending on results
from lower tier assays. The ability to relate
end points at testing Tiers 2 and 3 to those
used at the Tier 1 screens would be benefi-
cial, offering a mechanistic basis to support
ecological risk assessments (Figure 3) (16).
Therefore, the use of a short-term test proce-
dure on fish using selected biochemical para-
meters (e.g., VTG) would be desirable to
make such correlations on a clearer mecha-
nistic basis. This approach offers a practical
means to developing linkage tools for itera-
tion between field and laboratory that can be
used as necessary to support the predictive
risk assessment process (11,14). 
Currently, all fish early life-stage study
(ELS), PLC, and FFLC tests include critical
elements of growth and development, and
thereby are amenable to examination of thy-
roid hormone-related effects (26). In the
future, determination of such effects in fish
may be sufficient to detect potential effects
of thyroid-active compounds (with reference
to the mammalian Tier 1 data for thyroid
activity) and potentially negate the need for
duplicative testing with Amphibia. This pos-
sibility should be reviewed as data become
available; comparative research into this
aspect is highly desirable. Determination of
genetic sex differentiation in fish may also
prove useful and would enable the sex ratio
of phenotypically similar offspring to be
determined. Knowledge of the genotypic sex
ratio relative to the phenotypic sex ratio
would be useful, but markers for genetic sex
need to be developed for this purpose (53).
In conclusion, we support the conduct of
higher tier tests using fathead minnows as the
preferred test species for chronic studies of
compounds that are active in Tier 1 and that
are predicted to enter aquatic ecosystems. We
suggest, however, that the EDSTAC recom-
mendation to default to the conduct of
FFLC tests at Tier 2 is neither scientifically
optimal nor ethically responsible in terms of
the numbers of animals involved. Instead, we
recommend that a functionally equivalent
approach be considered, incorporating fish
ELS and PLC tests at Tier 2 and the FFLC
test at Tier 3 (Figure 3). Additional end
points may need to be incorporated into the
protocols for these various tests, and these
end points should be validated and their use-
fulness assessed before regulatory implemen-
tation. Subsequent measurements may be
targeted at different end points if the specific
mode of action of a compound is known
(e.g., androgens, aromatase inhibitors, thy-
roid-active chemicals). To be optimal, this
will require expert judgment and dialogue in
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the problem formulation and risk characteri-
zation phases of the ecological risk assessment
paradigm (11) (Figure 1). 
Higher tier invertebrate testing. EDSTAC
(1) and the consequent EDSP proposal (2)
both recommend the use of crustacean life-
cycle assays for higher tier testing, with daph-
nids or mysid shrimps as the suggested test
organisms. For daphnids, the EDSP proposes
a 3-week chemical exposure period (flow-
through conditions), and the end points cur-
rently evaluated include length of time for the
appearance of the first brood, body length of
F0 females, cumulative number of young pro-
duced per female, and effects on the F1 gener-
ation (number of offspring, offspring lengths,
and cumulative mortality). For the mysid
shrimp (Americamysis bahia), the test protocol
involves a 6-week chemical exposure period
(flow-through conditions), and the end points
currently evaluated include length of time for
the appearance of the first brood, sex determi-
nation (sex ratio), body length of males and
females, cumulative number of young pro-
duced per female, and effects on the F1 gener-
ation (number of males and females, body
length of males and females, and cumulative
mortality). 
Given the scope of EDSTAC and the
EDSP, the scientific criteria for selecting an
arthropod species to test for (anti)androgenic
or estrogenic effects is scientifically unclear,
although it is a pragmatic use of existing regu-
latory test guidelines. Nevertheless, we sup-
port the view that where aquatic invertebrates
may be exposed to endocrine-active sub-
stances, and because laboratory daphnid pop-
ulations consist of parthenogenetic females,
an alternative species to daphnids may be nec-
essary for the assessment of chronic effects of
endocrine disruptors in sexually reproducing
Crustacea. For example, the EDSTAC pro-
posal to consider mysid shrimp may be a valid
option for a chronic invertebrate species in
endocrine effects testing. The advantages are
that mysids have been widely used in regula-
tory ecotoxicology, they are a sexually dimor-
phic species, and there is an extensive
reference database on reproductive toxicity to
this species. Unfortunately, the chronic mysid
test includes several technical disadvantages,
which include major knowledge gaps regard-
ing the basic endocrinology of mysids; identi-
fication of the sexes is technically difficult,
and parental cannibalism upon offspring can
compromise assessment of reproductive out-
put. Given these aspects, reproduction studies
in other invertebrate species may prove to be
more suitable for this test. Positive features of
alternative invertebrate test guidelines would
include much easier culturing and testing pro-
cedures than those for the saltwater mysid and
use of freshwater or synthetic sea water for
culturing and chronic toxicity testing.
Currently, however, there are relatively
few data on the influence of endocrine dis-
ruptors on development and reproduction in
Crustacea, and further research is necessary.
Indeed, mysids and daphnids, like many
other arthropods, have a specific hormone
regulation for growth and reproduction,
namely the ecdysteroid system (54). This is
very different from the androgen- and estro-
gen-based regulation of reproduction in
mammals and oviparous vertebrates. The
EDSTAC suggestion that estrogen or andro-
gen disruptors are likely to interfere with the
ecdysteroid activity is speculation and does
not reflect the other hormonal mechanisms
known to be important in arthropods.
Additionally, juvenile hormones should be
considered in insects and crustaceans (55).
Although changes in estrogen and andro-
gen metabolism have been measured in
Daphnia magna exposed to high doses of
xenobiotics (56), the putative role of these
steroids in daphnid physiology remains
unclear. Baldwin et al. (56) also found that
high doses of diethylstilbestrol affected the
reproduction and growth of D. magna,
whereas Kopf (57) found a decrease in repro-
duction after exposure of D. magna to 17β-
estradiol in the low micrograms-per-liter
range. In contrast, Schweinfurth et al. (58)
found no effect of 17α-ethynylestradiol in D.
magna exposed at a level of several hundred
micrograms per liter. In conclusion, although
daphnids may show developmental and repro-
ductive effects associated with toxic effects of
vertebrate endocrine disruptors (56,59), there
is little evidence that such effects are mediated
via the ecdysteroid or juvenile hormones. In
addition to daphnids, a number of other
aquatic invertebrate species have been used to
evaluate development and reproductive effects
of vertebrate endocrine disruptors. Recent
work has shown inhibition of development
and reproduction in marine crustaceans (Tisbe
battagliai) by 20-hydroxyecdysone and
diethylstilbestrol (60). In contrast, life-cycle
(21 day) studies with this copepod species did
not show significant effects after exposure at
up to 100 mg/L of either 17β-estradiol,
estrone, or 17α-ethynylestradiol (61).
Protocols for developmental and reproductive
end points have also been produced for chi-
ronomids (62) and have been applied to
phthalates and other important classes of
industrial chemicals known to be endocrine
active (63,64). As part of the ongoing research
program of the European Chemical Industry,
a review addressing the use of aquatic inverte-
brates to detect endocrine activity potential
has been carried out in collaboration with the
U.K. Environment Agency (65). It was con-
cluded that the role of sex steroid hormones in
development and reproduction of arthropods
and the potential sites of action of endocrine
disruptors have yet to be established. In other
invertebrate taxa, however, there is clear evi-
dence of hormonal disruption. For example,
in gastropod molluscs, the biocide tributyl
tin is suggested to inhibit the aromatization
of testosterone in female snails, thus increas-
ing the endogenous androgen level in these
organisms (9,66).
The international Society of Environ-
mental Toxicology and Chemistry (SETAC)-
OECD expert workshop on Endocrine
Disruption in Invertebrates: Endocrinology,
Testing and Assessment (EDIETA) held in
the Netherlands in December 1998 has
recently published its conclusions (67). Key
aspects of invertebrate endocrinology and
physiology are discussed, together with labo-
ratory test methods and the use of aquatic
and terrestrial invertebrates for environmen-
tal monitoring and assessment. Many of the
standard methods for conducting toxicity
tests with invertebrates were reviewed at this
workshop: it was concluded that although no
methods were designed to specifically
evaluate endocrine disruption, many inverte-
brate tests include end points that may be
endocrine responsive (e.g., development,
growth, reproduction). It was highlighted,
however, that basic research on invertebrate
endocrinology for diverse taxa is urgently
needed to remedy our ignorance of mecha-
nisms of action, physiologic control, and hor-
mone structure and function in invertebrates.
Research was called for to evaluate known
endocrine disruptors with a variety of inver-
tebrate bioassays using a suite of designated
reference compounds (67).
In conclusion, for Crustacea and other
arthropods, juvenile and ecdysteroid hor-
mones appear to be more important than
vertebrate-type steroids in influencing sexual
differentiation, growth, and reproduction
(55). We therefore suggest that before imple-
menting the proposal to employ daphnid or
mysid life-cycle tests for endocrine disruptors,
it is essential to address the serious gaps in our
basic knowledge of endocrine function in
these and other invertebrate taxa. In terms of
invertebrates often used in ecological effects
characterization, further activity in this area
should be assisted by the recommendations
contained in the EDIETA workshop report.
Amphibian extended development and
reproduction. Although EDSTAC proposed a
higher-tier amphibian assay incorporating
extended development and reproduction, no
specific assay was described (1). Subject to
adequate research, we suggest that the
inclusion of such an amphibian chronic test
might be a technically viable option, but only
if triggered by lower tier tests and by exposure
characterization (Figure 3). From an ethical
perspective, research efforts need to address
the comparative effects of a range of 
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endocrine disruptors on fish versus amphibian
development and reproduction in order to
establish potential redundancy between the
higher-tier fish and amphibian test methods.
The merits and objectives of a specific test
with amphibian species on endocrine-dis-
rupting effects was discussed in the “Frog
metamorphosis screening assay” section. 
A validated frog chronic test for develop-
mental and reproductive effects may be justi-
fied at Tier 3 (Figure 3) if exposure is likely
to be significant and if the substance is active
in the Tier 2 frog metamorphosis test. For
relevance to the field situation on such a
case-by-case basis, this type of amphibian
chronic test should consider an ecologically
representative species (for the protection of
wild amphibian populations) together with
exposure characterization. 
Protocol Development and
Validation
Validation can be defined as the input control
technique used to detect any data that are
inaccurate, incomplete, or scientifically unrea-
sonable. The basic challenge is to demonstrate
that a given assay is both biologically mean-
ingful (ecologically relevant) and is repro-
ducible in the hands of the international 
scientific community. Screening assays should
also be able to resolve whether endocrine
interactions are due to the (anti)estrogenic,
androgenic, and thyroid activity of a given
substance. The critical objective of the Tier 1
screening assays is to detect chemicals that
may be active in vivo, thereby taking into
account bioavailability, comparative metabo-
lism, and excretion of a substance in animals.
Such in vivo screens should ideally avoid false
positives, but it is essential that the potential
for false negatives is minimized.
Interspecies comparisons. The validation
of in vivo assays should provide definition of
the similarities and differences between the
different animal species involved and be rele-
vant to wildlife populations of concern for a
valid ecological risk assessment process (11).
Wherever possible, compounds that have
been selected for the validation of mammalian
protocols should also be considered for the
validation of protocols with egg-laying
species. The development of endocrine-dis-
ruption tests with novel ecotoxicity test
species, for example Amphibia, is more prob-
lematic because the baseline data for their
reproductive biology and toxicology is far less
developed than is the case for existing OECD
test species. This basic problem should be rec-
ognized in drawing together a timetable of
validation for the wildlife protocols and par-
ticularly for the protocols on thyroid-active
developments. A similar challenge exists for
invertebrates; arthropod tests should first
establish the effects of endogenous hormones
and their active metabolites before blindly
testing xenobiotics as putative endocrine dis-
ruptors. This approach is being evaluated at
present using 20-hydroxyecdysone in a num-
ber of crustacean systems, including daphnids
(68) and harpacticoid copepods (60).
Selection of reference chemicals. A num-
ber of strategies for endocrine-disruptor
screening and testing include proposals for
protocols that are currently in the conceptual
phase of development. To ensure scientific
dialogue in protocol development from the
start and to avoid any party having to go
back in the future to repeat key studies, it is
essential that the international scientific
community agree on a list of reference
chemicals for use in research and develop-
ment as part of an integrated scientific effort
(69). The chemical selection process should
consider reference substances for each hor-
mone end point (namely, androgens, estro-
gens, and thyroid hormones; both negative
and positive controls), natural and man-
made substances, composition and definition
of reference substance purity, and verification
of chemical stability in the test systems. In
the current European Chemical Industry
aquatic research program, the endocrine-dis-
ruptor compounds selected include diethyl-
stilbestrol, 17α-ethynylestradiol, fadrozole,
flutamide, genistein, methoxychlor, methyl-
testosterone, 4-tert-pentylphenol, and the
pure antiestrogen ZM189,154 (33,70).
These compounds were principally chosen
in view of their published database from
mammalian systems, and the intention is to
generate comparative data for a range of ani-
mal species looking at a range of diverse
endocrine-disruptor end points. For inverte-
brates, the recent EDIETA workshop recom-
mended comparative research using a variety
of reference compounds including metho-
prene, precocene, 20-hydroxyecdysone, lute-
olin, fadrozole, methyltestosterone, flutamide,
4-tert-pentylphenol, ethynylestradiol, and the
anti-estrogen ZM189,154. In summary, the
method development and validation process
should be made a joint activity between gov-
ernmental regulators, international harmo-
nization organizations such as the OECD,
and industry research groups. Such positive
collaboration will help ensure that we make
best use of existing data, initiated research
programs, and collaborative activities in
order to avoid duplication and conflicting
approaches (71). Science is developing rapid-
ly in the endocrine-disruptor arena; we all
need to take such developments into account
during the development of prospective haz-
ard and risk assessment programs (72). 
Conclusions
We advocate the adoption of the existing eco-
logical risk assessment guidelines (11) for
addressing the risk characterization and risk
management of natural and synthetic
endocrine disruptors. Within these guidelines,
we propose that although the exposure char-
acterization phase remains in principle the
same for endocrine disruptors as for other
substances, there are convincing scientific
arguments for seeking to strengthen the
effects characterization (hazard assessment)
component to efficiently deal with potential
endocrine disruptors and their wildlife
impacts. In response to recommendations
from the EDSTAC (1) and proposed EDSP
(2), we suggest a refined set of screening and
testing tiers to optimize scientific iteration
between characterization of both exposure
and ecological effects, to minimize the num-
ber of animals required for testing, and to
make optimal use of public and commercial
testing resources. With a scientific flexibility
to allow incorporation of ideas from the
OECD and other scientific groups active in
the endocrine-disruptors area, the ECETOC
approach (Figure 3) is considered to offer an
optimal way forward for the development
and validation of new endocrine-disruptor
screening and testing protocols using select-
ed reference chemicals. Once validated tests
are available, the emphasis should be on the
use of higher-tier data for the ecological risk
assessment of both natural and synthetic
endocrine-disrupting substances.
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